Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New anti-platelet strategies].

G de Gaetano, C Cerletti

    Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
    |February 24, 2001
    PubMed
    Summary

    Discovering antiplatelet drugs in the 1960s paved the way for new strategies. Pharmacogenetics offers a promising avenue for developing targeted antiplatelet therapies, potentially benefiting individuals over broad patient groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lifestyle and biological factors influence the relationship between mental health and low-grade inflammation.

    Brain, behavior, and immunity·2019
    Same author

    Impact of combined healthy lifestyle factors on survival in an adult general population and in high-risk groups: prospective results from the Moli-sani Study.

    Journal of internal medicine·2019
    Same author

    Consumption of whole grain food and its determinants in a general Italian population: Results from the INHES study.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
    Same author

    Learning by counting blood platelets in population studies: survey and perspective a long way after Bizzozero.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Serum vitamin D deficiency and risk of hospitalization for heart failure: Prospective results from the Moli-sani study.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
    Same author

    Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation.

    Thrombosis research·2017

    Area of Science:

    • Pharmacology
    • Genetics
    • Cardiovascular Medicine

    Background:

    • Platelet inhibitory drugs, including aspirin, were identified in the 1960s, initially for other uses.
    • The pursuit of novel antiplatelet strategies has yielded moderate success, with development of selective molecules.
    • Recent advances in platelet pharmacology are reviewed, highlighting emerging therapeutic targets.

    Discussion:

    • Pharmacogenetics presents a novel approach to antiplatelet therapy development.
    • This field explores how genetic variations influence drug response.
    • Tailoring antiplatelet medications based on individual genetics could optimize treatment efficacy and safety.

    Key Insights:

    • Selective antiplatelet agents have been developed, but rational strategies remain a challenge.
    • Pharmacogenetics is emerging as a key area for future antiplatelet drug discovery.
    • Individualized medicine through pharmacogenetics may revolutionize antiplatelet treatment.

    Outlook:

    • Successful implementation of pharmacogenetics could lead to highly personalized antiplatelet drugs.
    • Future antiplatelet strategies may shift from population-based to individual-based approaches.
    • This personalized approach promises improved patient outcomes in cardiovascular care.

    Related Experiment Videos